Document is current
Any future updates will be listed below
-
Authors
,
Claessens, Anouk K. M.
Timman, Reinier
Busschbach, Jan J.
Bouma, Jeanette M.
Rademaker-Lakhai, Jeany M.
Erdkamp, Frans L. G.
Tjan-Heijnen, Vivianne C. G.
Bos, Monique E. M. M. https://orcid.org/0000-0002-9415-6342
-
Funding
Funding for this research was provided by:
Roche
Teva Pharmaceutical Industries
- License Information
-
More Information
Article History
Received: 24 July 2019
Accepted: 8 November 2019
First Online: 28 November 2019
Compliance with ethical standards
:
: We wish to draw the attention of the Editor to the following facts which the authors declare to be of no major conflict of interest to this work: AC, RT, JJB, JMB and JRL have nothing to declare. FE has received honoraria from Roche and Novartis and has a consulting/advisory role for these companies. VTH has received honoraria from Roche, E. Lilly and Pfizer; has a consulting or advisory role for Novartis, Pfizer, E. Lilly and Roche; has received research funding for her institution from E. Lilly, Roche, Eisai, Pfizer and Novartis; and has received travel, accommodations and/or expenses from Pfizer, Novartis, E. Lilly and Roche. MB has received travel, accommodations and/or expenses from Roche, Novartis, and Pfizer.
: The study was conducted according to the International Conference on Harmonization (ICH) and Good Clinical Practice (GCP) guidelines, in agreement with the Declaration of Helsinki (version 1 May 1996) and local regulations (ethics committee Eindhoven, the Netherlands).
: Written informed consent was obtained from all participants.
